ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
97,095.21
-0.68%
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs Yen
156.445
-0.01%
Brent Oil
72.72
0.00%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. BioMarin Pharmaceutical Inc (BMRN)

  7. BioMarin Pharmaceutical Inc (BMRN) ニュース

BMRN

BioMarin Pharmaceutical (BMRN)

BioMarin Pharmaceutical Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:BMRN
日付受信時刻ニュースソース見出しコード企業名
2024/12/0408 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/11/1700 : 45PR Newswire (US)BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024NASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/11/1504 : 44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/11/1304 : 27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/11/0622 : 00PR Newswire (US)BioMarin to Participate in Three Upcoming Investor ConferencesNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/11/0104 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/10/3005 : 04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/10/3005 : 03PR Newswire (US)BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and OutlookNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/10/2420 : 00GlobeNewswire Inc.Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug CandidateNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/10/1621 : 30PR Newswire (US)BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ETNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/10/0205 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/10/0205 : 50Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/10/0105 : 29Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/09/2421 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/09/1821 : 00PR Newswire (US)BioMarin to Present Data Underscoring Sustained Positive Impact of VOXZOGO® (vosoritide) on Health-Related Quality of Life, Growth and Maintenance of Bone Strength in Children with Achondroplasia at 2024 International Skeletal Dysplasia Society MeetingNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/09/1806 : 54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/09/0502 : 00PR Newswire (US)BioMarin Holds Investor Day; Provides New Corporate Strategy and Introduces 2027 Financial GuidanceNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/09/0501 : 52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/09/0420 : 30PR Newswire (US)BioMarin to Host Investor Day Today at 10:30 a.m. Eastern TimeNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/08/2921 : 00PR Newswire (US)BioMarin to Present at the 22nd Annual Morgan Stanley Global Healthcare Conference on Thursday, September 5 at 7:45 AM PT / 10:45 AM ET in New York, NYNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/08/2906 : 02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/08/2306 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/08/2121 : 30PR Newswire (US)BioMarin Announces New R&D and Business Development LeadershipNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/08/1922 : 00PR Newswire (US)BioMarin to Host 2024 Investor Day on September 4th in New YorkNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/08/1604 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/08/1400 : 48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/08/0605 : 35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/08/0605 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/08/0605 : 03PR Newswire (US)BioMarin Announces 20% Y/Y Total Revenue Growth in the Second Quarter and Increase in Full-year 2024 GuidanceNASDAQ:BMRNBioMarin Pharmaceutical Inc
2024/08/0605 : 01PR Newswire (US)BioMarin Announces Updated Strategy for ROCTAVIAN® to Focus on U.S., Germany and ItalyNASDAQ:BMRNBioMarin Pharmaceutical Inc
 Showing the most relevant articles for your search:NASDAQ:BMRN

最近閲覧した銘柄

NYSE
AXP
American Express
NYSE
XOM
Exxon Mobil
CCOM
US500
US 500
NYSE
CVX
Chevron
FX
USDEUR
US Dollar vs Euro
AMEX
XLF
Financial Select Sector
AMEX
XLV
Health Care Select Sector
FX
USDGBP
US Dollar vs Sterling
USOTC
RHHBY
Roche (QX)
NYSE
NKE
Nike
USI
USTECH100
US Tech 100
NASDAQ
MSFT
Microsoft
NASDAQ
AAPL
Apple
USOTC
BASFY
BASF (QX)
FX
USDJPY
US Dollar vs Yen
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有